PET/CT scan testing a new radioactive tracer for tumors
Part of Cancer, Hormones & metabolism, Skin, Women’s health & pregnancy clinical trials.
This early-phase study uses PET/CT scans to see how well a new radioactive tracer (a tiny dose of a special material) highlights solid tumors in the body. It may help researchers learn whether this tracer can better find and track tumor spots seen on standard scans.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a known or suspected solid tumor (not just blood cancers).
- You have at least one tumor spot/lesion that measures 1.0 cm or larger on standard scans (CT, MRI, ultrasound, or FDG PET/CT).
- You are able to safely complete the imaging procedures (lying still and tolerating the scan).
- You are not pregnant or breastfeeding at the time of screening (pregnancy testing may be done for people who could become pregnant).
- You do not have another medical problem that a study doctor thinks would make the scan unsafe or interfere with participation.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This Phase 1 study tests a new PET/CT imaging tracer to see how well it can detect breast cancer spots in the body. It may help doctors learn where breast cancer is and how imaging could work better in the future.
This study is testing a new type of PET scan that uses a special tracer to make tumors easier to see. It may help doctors get more accurate information about your tumor before you have a biopsy or surgery.
This trial uses a new radioactive tracer that attaches to a protein found on many solid tumors, allowing doctors to see tumors on a PET scan. It may help improve how tumors are detected and monitored.
This study tests a new imaging agent that helps PET scans show cancer more clearly. It may help doctors see where cancer is in your body and plan your treatment better.
This trial tests a new imaging agent that may help doctors see tumors more clearly during a PET scan. It is for people with certain types of cancer who are willing to have a biopsy of their tumor.
This trial uses a special PET scan to take pictures of certain solid tumors. The scan uses a new dye that may help doctors see the tumors more clearly. You may be eligible if you have one of the listed cancers and are between 18 and 75 years old with good daily function.
Hear when a new Breast Carcinoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.